The QWINT-1 study compared efsitora to daily injections of Sanofi’s SNY Lantus (insulin glargine) for 52 weeks in T2D ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

New data show Lilly’s longer-lasting insulin matched daily shots in controlling blood sugar, adding to positive findings the company disclosed in May.

You might take long-lasting shots at night, such as insulin detemir (Levemir) or insulin glargine (Lantus). Even if you change your lifestyle and take your medicine as directed, your blood sugar ...

The drug does this by: Increasing the amount of insulin your body makes after a meal so that your blood sugar levels won’t get too high. Insulin is a hormone that lowers your blood sugar levels.

29 lb more than participants on insulin degludec 27 lb more than participants on insulin glargine Mounjaro stimulates insulin production, helping to improve insulin resistance. It acts on GLP-1 ...

In people taking insulin for the first time, efsitora reduced A1C by 1.31% after one year of treatment, compared with a 1.27% reduction for insulin glargine.

compared with a 1.27% reduction for insulin glargine. "Many patients are reluctant to start insulin because of the burden it places on them," Jeff Emmick, senior vice president of product ...

The QWINT-1 study compared efsitora to daily injections of Sanofi’s SNY Lantus (insulin glargine) for 52 weeks in T2D patients using basal insulin for the first time. The QWINT-3 study compared ...